on KLEA HOLDING (isin : FR0013481835)
Klea Pharmaceuticals Launches Operations with a Strategic Partner
Klea Pharmaceuticals, a subsidiary of Klea Holding, is launching operations in the United Arab Emirates with a portfolio of 57 medications. This launch is being carried out in partnership with Al Khayyat Investments (AKI), a major player in pharmaceutical distribution in the Middle East.
Based in Dubai, Klea Pharmaceuticals will benefit from AKI's regional coverage to deploy its products. The partnership offers a strong growth opportunity in the rapidly expanding Middle Eastern and African pharmaceutical market, with projected revenues exceeding €2 million by 2026.
Regulatory procedures and operational structuring are underway, with finalization expected by June 2026. Entry into this market aims to capitalize on strong local demand for health products.
R. H.
Copyright © 2026 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all KLEA HOLDING news